Pauling David
- SEC CIK
- 0002063633
Latest role at each company
- STRO SUTRO BIOPHARMA, INC.Chief Admin. Ofcr. & GCas of Mar 6, 2026
Trades
Every Form 4 that lists Pauling David as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| STROSUTRO BIOPHARMA, INC. | Oct 16, 2025 | Oct 15, 2025 | Pauling DavidChief Admin. Ofcr. & GC | PPurchaseCommon Stock | +12.5K | $0.80 | +$10K | 71.74K | +21.1% | SEC |